Selected article for: "differential recombinant immunofluorescence assay and recombinant immunofluorescence assay"

Author: Aburizaiza, Asad S.; Mattes, Frank M.; Azhar, Esam I.; Hassan, Ahmed M.; Memish, Ziad A.; Muth, Doreen; Meyer, Benjamin; Lattwein, Erik; Müller, Marcel A.; Drosten, Christian
Title: Investigation of Anti–Middle East Respiratory Syndrome Antibodies in Blood Donors and Slaughterhouse Workers in Jeddah and Makkah, Saudi Arabia, Fall 2012
  • Cord-id: jrrkcefo
  • Document date: 2014_1_15
  • ID: jrrkcefo
    Snippet: Middle East respiratory syndrome coronavirus (MERS-CoV) is a novel, potentially zoonotic human coronavirus (HCoV). We investigated MERS-CoV antibodies using a staged approach involving an immunofluorescence assay (IFA), a differential recombinant IFA, and a plaque-reduction serum neutralization assay. In 130 blood donors sampled during 2012 in Jeddah and 226 slaughterhouse workers sampled in October 2012 in Jeddah and Makkah, Saudi Arabia, 8 reactive sera were seen in IFA but were resolved to be
    Document: Middle East respiratory syndrome coronavirus (MERS-CoV) is a novel, potentially zoonotic human coronavirus (HCoV). We investigated MERS-CoV antibodies using a staged approach involving an immunofluorescence assay (IFA), a differential recombinant IFA, and a plaque-reduction serum neutralization assay. In 130 blood donors sampled during 2012 in Jeddah and 226 slaughterhouse workers sampled in October 2012 in Jeddah and Makkah, Saudi Arabia, 8 reactive sera were seen in IFA but were resolved to be specific for established HCoVs by discriminative testing. There is no evidence that MERS-CoV circulated widely in the study region in fall 2012, matching an apparent absence of exported disease during the 2012 Hajj.

    Search related documents:
    Co phrase search for related documents
    • acute respiratory syndrome and livestock animal: 1, 2, 3, 4, 5, 6, 7, 8
    • acute respiratory syndrome and local population: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • acute respiratory syndrome and low avidity: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory syndrome and low avidity antibody: 1, 2